Klinische Indikationen für die PET am Herzen.

Keyphrases

• Clinical Indications 100%
• Revascularization 100%
• Metabolism 50%
• Clinical Application 50%
• Ammonia 50%
• Acetate 50%
• Therapeutic Outcome 50%
• Clinical Data 50%
• Thallium 50%
• 18F-fluorodeoxyglucose (18F-FDG) 50%
• Cardiac Perfusion 50%
• Cardiology 50%
• Valvular Heart Disease 50%
• Fatty Acids 50%
• Ligand Binding 50%
• Cardiac Transplantation 50%
• Drug Dosing 50%
• 99mTc-sestamibi 50%
• Drug Action 50%
• Chronic Myocardial Ischemia 50%
• Acute Myocardial Infarction 50%
• Cardiomyopathy 50%
• Myocardial Function 50%
• Dose Optimization 50%
• Spontaneous Excitatory Postsynaptic Current (sEPSC) 50%
• Rubidium 50%
• Regional Myocardial Function 50%
• Anaerobic Metabolism 50%
• Quantitative Visualization 50%
• Myocardial Innervation 50%
• MIBI Scan 50%
• Activity Optimization 50%

Medicine and Dentistry

• Polyethylene Terephthalate 100%
• Heart Function 50%
• Revascularization 50%
• Fluorodeoxyglucose F 18 25%
• Heart Perfusion 25%
• Carbon 11 25%
• Acetic Acid 25%
• Cardiology 25%
• Valvular Heart Disease 25%
• Fatty Acid 25%
• Heart Muscle Ischemia 25%
• Acute Heart Infarction 25%
• Myocardial Disease 25%
• Innervation 25%
• Heart Graft 25%
• Drug Activity 25%
• Nitrogen 13 25%
• Anaerobic Metabolism 25%
• Ligand Binding 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Polyethylene Terephthalate 100%
• Fluorodeoxyglucose F 18 25%
• Fatty Acid 25%
• Heart Muscle Ischemia 25%
• Acute Heart Infarction 25%
• Myocardial Disease 25%
• Carbon 11 25%
• Nitrogen 13 25%
• Valvular Heart Disease 25%